1-12 of 12
Omar Alkharabsheh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Daratumumab-Based Regimens in Anti-CD38 Treatment-Naïve Relapsed/Refractory Multiple Myeloma with High-Risk Cytogenetics

Jordan Snyder, Razan Mansour, Aytaj Mammadzadeh, Hamza Hashmi, Aimaz Afrough, Omar Alkharabsheh, Barry Paul, Shebli Atrash, Muhammad Umair Mushtaq, Barry S. Skikne, Nausheen Ahmed, Al-Ola Abdallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 1985.
https://doi.org/10.1182/blood-2023-187487
Published: 2023
Journal Articles

Outcomes of Vdpace for Relapsed/Refractory Multiple Myeloma in the Era of Daratumumab Based Therapy

Priyanka Venkatesh, Ghena Khasawneh, Hamza Hashmi, Omar Alkharabsheh, Barry Paul, Barry S. Skikne, Zahra Mahmoudjafari, Nausheen Ahmed, Al-Ola Abdallah, Shebli Atrash
Journal: Blood
Blood (2023) 142 (Supplement 1): 1971.
https://doi.org/10.1182/blood-2023-188117
Published: 2023
Journal Articles

Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Who Received at Least 2 BCMA-Directed Therapies

Jordan Snyder, Zain Alsaddi, Omar Alkharabsheh, Barry Paul, Forat Lutfi, Nausheen Ahmed, Zahra Mahmoudjafari, Al-Ola Abdallah, Shebli Atrash
Journal: Blood
Blood (2023) 142 (Supplement 1): 1969.
https://doi.org/10.1182/blood-2023-185231
Published: 2023
Journal Articles

Outcomes of Patients Who Are BCMA (B-cell maturation Antigen) Directed Therapy (BDT) Exposed Vs BCMA Naïve in Penta-Relapsed Refractory Multiple Myeloma (RRMM)

Aytaj Mammadzadeh, Fulei Peng, Shebli Atrash, Hamza Hashmi, Meera Mohan, Omar Alkharabsheh, Aimaz Afrough, Wei Cui, Zahra Mahmoudjafari, Al-Ola Abdallah
Journal: Blood
Blood (2022) 140 (Supplement 1): 4277–4278.
https://doi.org/10.1182/blood-2022-165762
Published: 2022
Journal Articles

Hemophagocytic Lymphohistiocytosis Clinical Features and Outcomes: Single Institution Case Series

Samuel Hall, Muhammad Ashfaq, Veena Krishnan, Sunil Badami, Omar Alkharabsheh
Journal: Blood
Blood (2022) 140 (Supplement 1): 11181–11182.
https://doi.org/10.1182/blood-2022-170305
Published: 2022
Journal Articles

Induction Quadruplet Therapy and Minimal/Measurable Residual Disease (MRD)-Informed Treatment Adaptation in Newly Diagnosed Multiple Myeloma (NDMM): Results from an Academic-Community Pathway

Gayathri Ravi, Smith Giri, Susan Bal, Kelly N. Godby, Vishnu V.B. Reddy, Donna Salzman, Omar Alkharabsheh, Scott A. McDaniel, Melissa Sentell, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 8048–8049.
https://doi.org/10.1182/blood-2022-170099
Published: 2022
Journal Articles

Daratumumab,Pomalidomide and Dexamethasone (DPd) Versus Daratumumab, Velcade and Dexamethasone (DVd) in Previously Treated Daratumumab Naïve Relapsed Refractory Multiple Myeloma Patients

Evguenia Ouchveridze, Chandandeep Singh, Shebli Atrash, Barry Paul, Meera Mohan, Omar Alkharabsheh, Aimaz Afrough, Wei Cui, Zahra Mahmoudjafari, Al-Ola Abdallah, Hamza Hashmi
Journal: Blood
Blood (2022) 140 (Supplement 1): 7164–7165.
https://doi.org/10.1182/blood-2022-168368
Published: 2022
Journal Articles

Marrow Blast Percentage Impact on High-Grade Myelodysplastic Syndrome By the Revised International Prognostic Scoring System

Omar Alkharabsheh, MBBS, Mrinal M. Patnaik, MD MBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Hassan B. Alkhateeb, MD, Mithun Vinod Shah, MD PhD, William J. Hogan, MBBCh, Rong He, MD, Patricia Greipp, DO, Phuong L. Nguyen, MD, Mark R. Litzow, MD, Aref Al-Kali, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5510.
https://doi.org/10.1182/blood-2018-99-113943
Published: 2018
Journal Articles

Impact of Significant Eosinophilia in Patients with Myelodysplastic Syndromes: Single Institution Experience

Salwa S Saadeh, MBBS, Omar Alkharabsheh, MD, Darci Zblewski, CNP, Mrinal M. Patnaik, MDMBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Hassan B. Alkhateeb, MD, Michelle A. Elliott, MD, Rong He, MD, Phuong Nguyen, MD, William J. Hogan, MBBCh, Mark R. Litzow, MD, Aref Al-Kali, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5310.
https://doi.org/10.1182/blood.V130.Suppl_1.5310.5310
Published: 2017
Journal Articles

Risk of Venous Thrombotic Events (VTE) in Patients with Myelodysplastic Syndromes with 5q Deletion during Lenalidomide Therapy: Single Institution Experience

Omar Alkharabsheh, MD, Darci Zblewski, CNP, Naseema Gangat, MBBS, Kebede H. Begna, MD, Michelle A. Elliott, MD, Hassan B. Alkhateeb, MD, Mrinal M. Patnaik, MDMBBS, William J. Hogan, MBBCh, Mark R. Litzow, MD, Aref Al-Kali, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5315.
https://doi.org/10.1182/blood.V130.Suppl_1.5315.5315
Published: 2017
Journal Articles

Prevalence of Occult Celiac Disease in Females with Iron Deficiency in the United States: An Nhanes Analysis.

Ahmed Abdalla, MD, Shaik Mohamed Saifullah, MD, Mohamed Osman, MD, Ramkaji Baniya, MD, Shima Sidahmed, MD, Omar Alkharabsheh, MD, Jenny LaChance, MS, Ghassan Bachuwa, MD MHSA, MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 939.
https://doi.org/10.1182/blood.V130.Suppl_1.939.939
Published: 2017
Journal Articles

Title: Poor Long-Term Outcomes of Patients with Human Herpesvirus 6 Encephalitis

Omar Abu Saleh, MBBS, Alexandra Bryson, PhD, Omar Alkharabsheh, MD, Raymund Razonable, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4829.
https://doi.org/10.1182/blood.V130.Suppl_1.4829.4829
Published: 2017